Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rita Nanda, MD
University of Chicago
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Acrc/arizona Clinical Research Center Inc.
Tucson, Arizona, United States
- H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- Rita Nanda, Md
Chicago, Illinois, United States
- Quest Research
Royal Oaks, Michigan, United States
- St. Luke'S Cancer Institute
Kansas City, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Texas Oncology-Baylor Charles A. Sammons Cancer Center
Dallas, Texas, United States
- Cancer Care Centers of South Texas
San Antonio, Texas, United States
- Texas Oncology - Tyler
Tyler, Texas, United States
- Virginia Cancer Specialists
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2014
- Primary completion
- 31 Dec 2017
- Completion
- 31 Dec 2017
- Last update posted
- 17 Jan 2018
- Registered enrollment
- 37
- Registry id
- NCT02014337
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.